Citation Impact
Citing Papers
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
2007
Role of Genotype in the Cycle of Violence in Maltreated Children
2002 StandoutScience
Medication Augmentation after the Failure of SSRIs for Depression
2006 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
S33005, a Novel Ligand at Both Serotonin and Norepinephrine Transporters: II. Behavioral Profile in Comparison with Venlafaxine, Reboxetine, Citalopram, and Clomipramine
2001
5-Hydroxytryptamine pathways in anxiety and its treatment
1995
The neural basis of drug craving: An incentive-sensitization theory of addiction
1993 Standout
A Neurotrophic Model for Stress-Related Mood Disorders
2006 Standout
25 Years since the discovery of presynaptic receptors: present knowledge and future perspectives
1997
Merkel Cells Activate Sensory Neural Pathways through Adrenergic Synapses
2018 StandoutNobel
Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD.
1997 Standout
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Oral Erythromycin and the Risk of Sudden Death from Cardiac Causes
2004
Serotonin-Induced Increases in Adult Cell Proliferation and Neurogenesis are Mediated Through Different and Common 5-HT Receptor Subtypes in the Dentate Gyrus and the Subventricular Zone
2003
Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect
2001
Cell Proliferation in Adult Hippocampus is Decreased by Inescapable Stress: Reversal by Fluoxetine Treatment
2003
From Threat to Fear: The Neural Organization of Defensive Fear Systems in Humans
2009 StandoutNobel
Spinal-cord injury
2002 Standout
Is the forced swimming test a suitable model for revealing antidepressant activity?
1988
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
2005 Standout
Dopamine Partial Agonists
2004
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012
Intrahippocampal spermidine administration improves inhibitory avoidance performance in rats
2000
Assessing psychopathic attributes in a noninstitutionalized population.
1995 Standout
Eliprodil, a non-competitive, NR2B-selective NMDA antagonist, protects pyramidal neurons in hippocampal slices from hypoxic/ischemic damage
1998
Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1β in the rat
2001
The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior
2007
5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research
1995
Parkinson's disease
2009 Standout
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
The Non-Antiemetic Uses of Serotonin 5-HT3 Receptor Antagonists
1997
5-HT1A receptor ligands in animal models of anxiety, impulsivity and depression: Multiple mechanisms of action?
1993
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
2011 StandoutNature
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Mechanism of Action of St John???s Wort in Depression
2003
Novelty and Anxiolytic Drugs Dissociate Two Components of Hippocampal Theta in Behaving Rats
2013 StandoutNobel
Treatment of male infertility due to spinal cord injury using rectal probe electroejaculation: the Israeli experience
2001
Effects of antidepressants on cognitive functions: A review
1995
Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission
1999 StandoutNatureNobel
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
Neurobiology of Depression
2002 Standout
Behavioral and neurochemical characterization of α2A-adrenergic receptor knockout mice
2002 StandoutNobel
Major Depressive Disorder
2008 Standout
Exercise Enhances Learning and Hippocampal Neurogenesis in Aged Mice
2005 Standout
AKT/PKB Signaling: Navigating the Network
2017 Standout
How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
2008
Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test
1998
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
The molecular neurobiology of depression
2008 StandoutNature
Amisulpride – a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials
2004
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
Serotonin in Affective Control
2009
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Brain monoamine oxidase A inhibition in cigarette smokers
1996
The 5-HT3Subtype of Serotonin Receptor Contributes to Nociceptive Processing via a Novel Subset of Myelinated and Unmyelinated Nociceptors
2002 StandoutNobel
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors.
1996 StandoutNobel
Place navigation impaired in rats with hippocampal lesions
1982 StandoutNatureNobel
5-HT and mechanisms of defence
1991
Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology - a double-blind controlled study comparing a selective D 2 -like antagonist to a mixed D 1 -/D 2 -like antagonist
1998
When Fear Is Near: Threat Imminence Elicits Prefrontal-Periaqueductal Gray Shifts in Humans
2007 StandoutScienceNobel
Effects of neuroleptic drugs, clonidine and lithium on the expression of conditioned behavioral excitation in rats
1987
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease
1997 StandoutNobel
Spermidine in health and disease
2018 StandoutScience
Goal constructs in psychology: Structure, process, and content.
1996 Standout
About Sleep's Role in Memory
2013 Standout
Emotion Circuits in the Brain
2000 Standout
Ischemic Cell Death in Brain Neurons
1999 Standout
Serotonin Receptors
2008
Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression
2002
The Neuropsychology of Anxiety
2003 Standout
Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus
2000 Standout
Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants
2003 StandoutScience
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
1996 StandoutScience
Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: The BIS/BAS Scales.
1994 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
MONOAMINE OXIDASE: From Genes to Behavior
1999
EAT-4, a Homolog of a Mammalian Sodium-Dependent Inorganic Phosphate Cotransporter, Is Necessary for Glutamatergic Neurotransmission inCaenorhabditis elegans
1999 StandoutNobel
Works of A Puech being referenced
Treatment of Negative Symptoms in Schizophrenia with Amisulpride
1995
Lack of amnestic, psychotomimetic or impairing effect on psychomotor performance of eliprodil, a new NMDA antagonist
1994
A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder
1993
Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism
1990
Antidepressant-like effects of buspirone mediated by the 5-HT1A post-synaptic receptors in the learned helplessness paradigm
1991
Monoamine oxidase A and B activities in heavy smokers
1995
U-43,465F: a triazolobenzodiazepine with pronounced antidepressant-like as well as anxiolytic activities in animals.
1983
Antimanic effect of clonidine
1980
Dose related effects of trimipramine on psychomotor function, memory, and autonomic nervous system activity in healthy volunteers
1989
Animal Behavioural Studies in the Evaluation of Antidepressant Drugs
1992
Treatment of anejaculation in the total paraplegic by subcutaneous injection of physostigmine
1983
Troleandomycin-triazolam interaction in healthy volunteers: Pharmacokinetic and psychometric evaluation
1987